FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

416848004: Substance with human alpha1 proteinase inhibitor mechanism of action (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2549380018 Human alpha1 proteinase inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
    3520749013 Substance with human alpha1 proteinase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3520919017 Substance with human alpha1 proteinase inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module
    101151701000001119 Human alpha1-proteinase inhibitor en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Substance with human alpha1 proteinase inhibitor mechanism of action Is a Alpha1-proteinase inhibitor false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Is a Human alpha1 proteinase inhibitor false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Is a Substance with proteinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Has disposition Human alpha1 proteinase inhibitor false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Has disposition Coagulation factor inhibitor false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Has disposition Serine protease inhibitor false Inferred relationship Existential restriction modifier
    Substance with human alpha1 proteinase inhibitor mechanism of action Has disposition Acute phase reactant false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing human alpha1 proteinase inhibitor Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1 proteinase inhibitor 1000mg powder for injection solution vial Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Product containing precisely human alpha1 proteinase inhibitor 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1 proteinase inhibitor 500mg injection solution vial + diluent Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1 proteinase inhibitor 1000mg injection solution vial + diluent Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Product containing precisely human alpha1 proteinase inhibitor 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1 proteinase inhibitor 500mg powder for conventional release solution for injection vial Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1-proteinase inhibitor 1g powder and solvent for solution for infusion vials Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1-proteinase inhibitor 1g powder and solvent for solution for infusion vials Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Prolastin 1g powder and solvent for solution for infusion vials (Imported (Germany)) Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Prolastin 1g powder and solvent for solution for infusion vials (Imported (Germany)) Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Human alpha1-proteinase inhibitor 1g powder and solvent for solution for infusion vials 1 vial Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Prolastin 1g powder and solvent for solution for infusion vials (Imported (Germany)) 1 vial Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Respreeza 1000mg powder and solvent for solution for infusion vials (CSL Behring UK Ltd) Has active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Respreeza 1000mg powder and solvent for solution for infusion vials (CSL Behring UK Ltd) Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
    Respreeza 1000mg powder and solvent for solution for infusion vials (CSL Behring UK Ltd) 1 vial Has specific active ingredient False Substance with human alpha1 proteinase inhibitor mechanism of action Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start